Injectable Devices for Delivery of Liquid or Solid Protein Formulations

[1]  A. Lamprecht,et al.  Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates , 2022, Pharmaceutics.

[2]  D. Eichenbaum,et al.  Ranibizumab port delivery system: a clinical perspective , 2022, BMJ Open Ophthalmology.

[3]  Yoonjee C. Park,et al.  Long-term Antibody Release Polycaprolactone (PCL) Capsule and the Release Kinetics In Natural and Accelerated Degradation , 2022, bioRxiv.

[4]  C. Waeber,et al.  Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies. , 2022, Advanced drug delivery reviews.

[5]  S. Mitragotri,et al.  The evolution of commercial drug delivery technologies , 2021, Nature Biomedical Engineering.

[6]  A. Peters,et al.  The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps , 2020, Ear, nose, & throat journal.

[7]  J. Kesavadev,et al.  Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas , 2020, Diabetes Therapy.

[8]  Tanja Narancic,et al.  Recent Advances in Bioplastics: Application and Biodegradation , 2020, Polymers.

[9]  A. Palmer,et al.  Injectable biodegradable bi-layered capsule for sustained delivery of bevacizumab in treating wet age-related macular degeneration. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Dietmar W. Hutmacher,et al.  Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment , 2019, Progress in Polymer Science.

[11]  T. Desai,et al.  Recent advances in intraocular sustained-release drug delivery devices. , 2019, Drug discovery today.

[12]  Venkata Raman Kallakunta,et al.  An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I , 2019, Expert opinion on drug delivery.

[13]  R. Henn,et al.  Biologic Therapies for the Treatment of Knee Osteoarthritis. , 2019, The Journal of arthroplasty.

[14]  T. Desai,et al.  Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device. , 2019, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[15]  Michael R Hamblin,et al.  Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. , 2019, Nanomedicine.

[16]  Tejal A. Desai,et al.  Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery , 2018, Bioengineering & translational medicine.

[17]  Yatin R. Gokarn,et al.  Non-invasive delivery strategies for biologics , 2018, Nature Reviews Drug Discovery.

[18]  A. Daugherty,et al.  Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response. , 2017, Investigative ophthalmology & visual science.

[19]  T. Desai,et al.  Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma , 2016, Investigative ophthalmology & visual science.

[20]  T. Desai,et al.  In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device , 2016, Drug Delivery and Translational Research.

[21]  Leonie Moench,et al.  Introduction To Polymers , 2016 .

[22]  S. Whitcup,et al.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.

[23]  Samir Mitragotri,et al.  An overview of clinical and commercial impact of drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[24]  C. Meyer,et al.  Penetration force, geometry, and cutting profile of the novel and old Ozurdex needle: the MONO study. , 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[25]  N. Rathore,et al.  Sterile Product Development , 2013, AAPS Advances in the Pharmaceutical Sciences Series.

[26]  Juergen Siepmann,et al.  Modeling of diffusion controlled drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[28]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[29]  P. Leggat,et al.  SURGICAL APPLICATIONS OF CYANOACRYLATE ADHESIVES: A REVIEW OF TOXICITY , 2007, ANZ journal of surgery.

[30]  Randall J Mrsny,et al.  Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.

[31]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[32]  K. Gekko,et al.  Compressibility of globular proteins in water at 25.degree.C , 1979 .

[33]  M. Himmel,et al.  Hydrodynamics and protein hydration. , 1979, Archives of biochemistry and biophysics.